|
Michael T. Sember has served as a director of the Company since May of 1997. Mr. Sember is the President and CEO of DOR BioPharma a biopharmaceutical company focused on the development of biomedical countermeasures and therapeutic products. Previously he was a Managing Director of EGB Advisors LLC a San Francisco based consulting firm and biotech incubator. From 2002 through 2003 Mr. Sember was an independent consultant providing strategic business development and executive services to a number of public and private companies including several which engaged him to assist in their efforts to accomplish a turn around and/or restructuring. Mr. Sember served as President and Chief Operating Officer of Women's First Healthcare Inc. from September to December 2003 and as President and Chief Operating Officer of Deltagen Inc. from April 2002 to December 2002. Mr. Sember was Executive Vice President of Business Development for Elan Corporation plc. from 1992 to 2002. Mr. Sember was with Marion Merrell Dow Inc. from 1973 to 1991. Mr. Sember received a Bachelor of Science degree from the University of Pittsburgh and an MBA from Rockhurst College. | 